Immunohistochemical Detection of Lymph Nodes Micrometastases in Patients of Pathologic Stage I Non-small-cell Lung Cancer
![]() ![]() |
Ryu, Jeong-Seon
(Department of Internal Medicine, College of Medicine, Inha University)
Han, Hye-Seung (Department of Pathology, College of Medicine, Konkuk University) Kim, Min-Ji (Department of Internal Medicine, College of Medicine, Inha University) Kwak, Seung-Min (Department of Internal Medicine, College of Medicine, Inha University) Cho, Jae-Hwa (Department of Internal Medicine, College of Medicine, Inha University) Yoon, Yong-Han (Department of Chest Surgery, College of Medicine, Inha University) Lee, Hong-Lyeol (Department of Internal Medicine, College of Medicine, Inha University) Chu, Young-Chae (Department of Pathology, College of Medicine, Inha University) Kim, Kwang-Ho (Department of Chest Surgery, College of Medicine, Inha University) |
1 | Dobashi K, Sugio K, Osaki T, Oka T, Yasumoto K. Micrometastatic p53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance.J Thorac Cardiovasc Surg 1997;114:339-46 |
2 | Betz C, Papadopoulos T, Buchwald J, Dammrich J, Muller-Hermelink HK. Surfactant protein gene expression in metastatic and micrometastatic pulmonary adenocarcinomas and other non-small cell lung carcinomas: detection by reverse transcriptasepolymerase chain reaction. Cancer Res 1995;55:4283-6 |
3 | Iwao K, Watanabe T, Fujiwara Y, Takami K, Kodama K, Higashiyama M, et al. Isolation of a novel human lung-specific gene, LUNX, a potential molecularmarker for detection of micrometastasis in nonsmall-cell lung cancer. Int J Cancer 2001;91:433-7 |
4 | Goldstein NS, Mani A, Chmielewski G, Welsh R, Pursel S. Immunohistochemically detected micrometastases in peribronchial and mediastinal lymph nodes from patients with T1, N0, M0 pulmonary adenocarcinomas. Am J Surg Pathol 2000;24:274-9 |
5 | Chen ZL, Perez S, Holmes EC, Wang HJ, Coulson WF, Wen DR, et al. Frequency and distribution of occult micrometastases in lymph nodes of patientswith non-small-cell lung carcinoma. J Natl Cancer Inst 1993;85:493-8 |
6 | Prognostic importance of axillary lymph node metastases from breast cancers. International(Ludwig) Breast Cancer Study Group. Lancet 1990;335:1565-8 |
7 | Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7 |
8 | Hashimoto T, Kobayashi Y, Ishikawa Y, Tsuchiya S, Okumura S, Nakagawa K, et al. Prognostic value of genetically diagnosed lymph node micrometastasis innon-small cell lung carcinoma cases. Cancer Res 2000;60:6472-8 |
9 | Tanaka F, Miyahara R, Ohtake Y, Yanagihara K, Fukuse T, Hitomi S, et al. Advantage of postoperative oral administration of UFT(tegafur and uracil) for completely resected p-stage I-IIIa nonsmall cell lung cancer(NSCLC). Eur J Cardiothorac Surg 1998;14(3):256-62 |
10 | Gu CD, Osaki T, Oyama T, Inoue M, Kodate M, Dobashi K, et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completelyresected nonsmall cell lung cancer: impact on recurrence and Survival. Ann Surg 2002;235:133-9 |
11 | Maruyama R, Sugio K, Fukuyama Y, Hamatake M, Sakada T, Saitoh G, et al. Evaluation of p53 alterations in occult lymph node metastases. J Surg Oncol 2000;73:143-7 |
12 | Kawano R, Hata E, Ikeda S, Sakaguchi H. Micrometastasis to lymph nodes in stage I left lung cancer patients. Ann Thorac Surg 2002;73(5):1558-62 |
13 | Nicholson AG, Graham AN, Pezzella F, Agneta G, Goldstraw P, Pastorino U. Does the use of immunhistochemistry to identify micrometastases provideuseful information in the staging of node-negative non-small cell lung carcinomas? Lung Cancer 1997;18:231-40 |
14 | Salerno CT, Frizelle S, Niehans GA, Ho SB, Jakkula M, Kratzke RA, et al. Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction. Chest 1998;113:1526-32 |
15 | Endo C, Saito Y, Iwanami H, Tsushima T, Imai T, Kawamura M, et al. A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery. Lung Cancer 2003;40(2):181-6 |
16 | Jiao X, Krasna MJ. Clinical Significance of Micrometastasis in Lung and Esophageal Cancer: A New Paradigm in Thoracic Oncology. Ann Thorac Surg2002;74:278-84 |
17 | Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;22;350(4):351-60 |
18 | Ohta Y, Nozawa H, Tanaka Y, Oda M, Watanabe Y. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreasednm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2000;119:804-13 |
![]() |